2,5-Dihydro-2,4,5-trimethyloxazole

Metabolite details

Identifier

YFSGRMONVCFYTC-UHFFFAOYSA-N

InChI Key

YFSGRMONVCFYTC-UHFFFAOYSA-N

IUPAC name

2,4,5-trimethyl-2,5-dihydro-1,3-oxazole

Preferred name

2,5-Dihydro-2,4,5-trimethyloxazole

INN name

—

Synonym

—

ChEBI

CHEBI:173328

Reactome pathways

• No Reactome pathways listed for this metabolite.

Observed in studies

• Bioaccumulation of therapeutic drugs by human gut bacteria: cross-feeding metabolite analysis (FIA-MS) (E.rectale;S.salivarius assays)
• Metabolic Dynamics of In Vitro CD8+ T Cell Activation.
• Multi-Omics Analysis Reveals Disturbance of Nanosecond Pulsed Electric Field in the Serum Metabolic Spectrum and Gut Microbiota
• Metabolic Responses of a Model Green Microalga Euglena gracilis to Different Environmental Stresses
• Diallyl disulfide (DADS) ameliorates intestinal Candida albicans infection by modulating the gut microbiota and metabolites and providing intestinal protection in mice
• Interaction between Cervical Microbiota and Host Gene Regulation in Caesarean Section Scar Diverticulum
• Mechanism of interventional effect and targets of Zhuyu Pill in regulating and suppressing colitis and cholestasis
• Transcriptomic and lipidomic profiling of subcutaneous and visceral adipose tissues in 15 vertebrates

Observed in differential profiles

• G4_Eubacterium_rectale_DMSO_30_vs_G3_Eubacterium_rectale_Duloxetine_47
• G3_Experimental_Sample_0h_vs_G11_Experimental_Sample_96h
• Control_vs_nsPEF_7_day
• Control_vs_Paramycin
• G1_PBS_vs_G2_DSS
• Control_vs_CSD
• Control_vs_ZYP_High_Dose
• G1_Sheep_ASA_SAT_vs_G2_Sheep_GOM_VAT